全文获取类型
收费全文 | 5684篇 |
免费 | 343篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 178篇 |
妇产科学 | 118篇 |
基础医学 | 813篇 |
口腔科学 | 247篇 |
临床医学 | 439篇 |
内科学 | 1541篇 |
皮肤病学 | 129篇 |
神经病学 | 574篇 |
特种医学 | 131篇 |
外科学 | 455篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 317篇 |
眼科学 | 26篇 |
药学 | 372篇 |
中国医学 | 5篇 |
肿瘤学 | 694篇 |
出版年
2024年 | 12篇 |
2023年 | 52篇 |
2022年 | 139篇 |
2021年 | 180篇 |
2020年 | 115篇 |
2019年 | 136篇 |
2018年 | 164篇 |
2017年 | 111篇 |
2016年 | 147篇 |
2015年 | 172篇 |
2014年 | 247篇 |
2013年 | 303篇 |
2012年 | 472篇 |
2011年 | 436篇 |
2010年 | 260篇 |
2009年 | 225篇 |
2008年 | 406篇 |
2007年 | 396篇 |
2006年 | 378篇 |
2005年 | 375篇 |
2004年 | 310篇 |
2003年 | 298篇 |
2002年 | 312篇 |
2001年 | 31篇 |
2000年 | 18篇 |
1999年 | 24篇 |
1998年 | 50篇 |
1997年 | 45篇 |
1996年 | 31篇 |
1995年 | 37篇 |
1994年 | 28篇 |
1993年 | 14篇 |
1992年 | 18篇 |
1991年 | 16篇 |
1990年 | 15篇 |
1989年 | 9篇 |
1988年 | 11篇 |
1987年 | 3篇 |
1986年 | 16篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1980年 | 5篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有6081条查询结果,搜索用时 15 毫秒
991.
992.
Giovanna Dipasquale Philippe NouetMichel Rouzaud Angèle DuboulozRaymond Miralbell Thomas Zilli 《Radiotherapy and oncology》2014
Objective
To assess in vivo dose distribution using cone-beam computed tomography scans (CBCTs) and thermoluminescent dosimeters (TLDs) in patients with anal or rectal cancer treated with volumetric modulated arc therapy (VMAT).Methods
Intracavitary (IC) in vivo dosimetry (IVD) was performed in 11 patients using adapted endorectal probes containing TLDs, with extra measurements at the perianal skin (PS) for anal margin tumors. Measured doses were compared to calculated ones obtained from image fusion of CBCT with CT treatments plans.Results
A total of 55 IC and 6 PS measurements were analyzed. IC TLD median planned and measured doses were 1.81 Gy (range, 0.25–2.02 Gy) and 1.82 Gy (range, 0.19–2.12 Gy), respectively. In comparison to the planned doses all IC TLD dose measurements differed by a median dose of 0.02 Gy (range, −0.11/+0.19 Gy, p = 0.102) (median difference of 1.1%, range −6.1%/+10.6%). Overall, 95% of IC measurements were within ±7.7% of the expected percentage doses and only 1 value was above +10%. For PS measurements, only one was not within ±7.7% of expected values (i.e., −8.9%).Conclusions
Image guidance using CBCT for IVD with TLDs is helpful to validate the delivered doses in patients treated with VMAT for ano-rectal tumors. 相似文献993.
Peter J Smith Alexandra Clavarino Jeremy Long Kathryn J Steadman 《Asia-Pacific Journal of Clinical Oncology》2014,10(1):1-10
Complementary and alternative medicine (CAM) cover a broad and diverse group of treatments and products that do not tend to be widely used by conventional healthcare professions. CAM that is systemically absorbed is the most likely to interfere with concurrent chemotherapy and potentially cause harm to cancer patients. Patients receiving chemotherapy may be consuming CAM to treat cancer, to lessen chemotherapy side effects, for symptom management, or to treat conditions unrelated to their cancer. A small proportion of cancer patients decide to use CAM alone to treat cancer and delay conventional treatment. Cancer patients may be influenced in their CAM decision‐making by others: practitioners, family, friends, spouse and even casual acquaintances met in waiting rooms and support groups. This influence may range from encouraging and supporting the patient's decision through to making the decisions for the patient. When tested in rigorous clinical trials, no CAM cancer treatments alone have shown benefit beyond placebo. With the exception of ginger to treat chemotherapy‐induced nausea, there is no compelling evidence overriding risk to take complementary medicines for supportive care during chemotherapy treatment. There is, however, established evidence to use mind–body complementary therapies for supportive care during chemotherapy treatment. 相似文献
994.
Different Effects of Regenerative and Direct Mitogenic Stimuli on the Growth of Initiated Cells in the Resistant Hepatocyte Model 总被引:2,自引:0,他引:2
Pierpaolo Coni Giuseppina Pichiri-Coni Marcello Curto Gabriella Simbula Laura Giacomini Dittakavi S. R. Sarma Giovanna M. Ledda-Columbano Amedeo Columbano 《Cancer science》1993,84(5):501-507
The possible mechanism(s) responsible for the different effects exerted by proliferative stimuli of different nature on the appearance of enzyme-altered hepatic foci, were investigated in male Wistar rats. Rats given an initiating dose of diethylnitrosamine (150 mg/kg body weight) were fed a diet containing 0.03% acetylaminofluorene for 2 weeks. Between the first and the second week, cell proliferation was induced by a proliferative stimulus of compensatory type (partial hepatectomy) or by a direct mitogenic stimulus (lead nitrate, 100 μmol/kg). The effect of the two different proliferative stimuli on the appearance of γ -glutamyl transferase-positive foci was monitored by killing the rats for examination at 1, 2, 3, 5, and 6 days after the induction of cell proliferation. The results indicate that while enzyme-altered hepatocytes can be observed as early as 3 days after partial hepatectomy and are characterized by a rapid growth, direct hyperplasia did not exert any effect on the growth capacity of initiated cells. No effect of lead nitrate-induced hyperplasia was observed following three administrations of the mitogen. When platelet-poor plasma taken from animals exposed to the different proliferative stimuli was tested in primary cultures of hepatocytes, it was found that it induced a significant increase in the labeling index of normal hepatocytes. However, while serum taken 6 days after partial hepatectomy was still able to induce a significant increase in the labeling index, platelet-poor plasma from lead-treated rats had lost part of its effect at 5 days after treatment. The inability of direct hyperplasia to stimulate the development of enzyme-altered hepatic foci was not unique to lead nitrate since the same phenomenon was observed when three other hepatomitogens, nafenopin, cyproterone acetate, and ethylene dibromide, were used. 相似文献
995.
Giovanna Bianchi Roberto Martella Silvia Ravera Cecilia Marini Selene Capitanio Annamaria Orengo Laura Emionite Chiara Lavarello Adriana Amaro Andrea Petretto Ulrich Pfeffer Gianmario Sambuceti Vito Pistoia Lizzia Raffaghello Valter D. Longo 《Oncotarget》2015,6(14):11806-11819
Tumor chemoresistance is associated with high aerobic glycolysis rates and reduced oxidative phosphorylation, a phenomenon called “Warburg effect” whose reversal could impair the ability of a wide range of cancer cells to survive in the presence or absence of chemotherapy. In previous studies, Short-term-starvation (STS) was shown to protect normal cells and organs but to sensitize different cancer cell types to chemotherapy but the mechanisms responsible for these effects are poorly understood. We tested the cytotoxicity of Oxaliplatin (OXP) combined with a 48hour STS on the progression of CT26 colorectal tumors. STS potentiated the effects of OXP on the suppression of colon carcinoma growth and glucose uptake in both in vitro and in vivo models. In CT26 cells, STS down-regulated aerobic glycolysis, and glutaminolysis, while increasing oxidative phosphorylation. The STS-dependent increase in both Complex I and Complex II-dependent O2 consumption was associated with increased oxidative stress and reduced ATP synthesis. Chemotherapy caused additional toxicity, which was associated with increased succinate/Complex II-dependent O2 consumption, elevated oxidative stress and apoptosis.These findings indicate that the glucose and amino acid deficiency conditions imposed by STS promote an anti-Warburg effect characterized by increased oxygen consumption but failure to generate ATP, resulting in oxidative damage and apoptosis. 相似文献
996.
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer
Emanuela Guerra Marco Trerotola Valeria Relli Rossano Lattanzio Romina Tripaldi Giovanna Vacca Martina Ceci Khouloud Boujnah Valeria Garbo Antonino Moschella Romina Zappacosta Pasquale Simeone Robert de Lange Ulrich H. Weidle Maria Teresa Rotelli Arcangelo Picciariello Raffaella Depalo Patrizia Querzoli Massimo Pedriali Enzo Bianchini Domenico Angelucci Giuseppe Pizzicannella Carla Di Loreto Mauro Piantelli Laura Antolini Xiao-Feng Sun Donato F. Altomare Saverio Alberti 《Neoplasia (New York, N.Y.)》2021,23(9):898
997.
Marco Cespi Giulia Bonacucina Giovanna Mencarelli Luca Casettari Giovanni Filippo Palmieri 《European journal of pharmaceutics and biopharmaceutics》2011,79(2):458-463
It is common practice to coat oral solid dosage forms with polymeric materials for controlled release purposes or for practical and aesthetic reasons. Good knowledge of thermo-mechanical film properties or their variation as a function of polymer grade, type and amount of additives or preparation method is of prime importance in developing solid dosage forms. This work focused on the dynamic mechanical thermal characteristics of free films of hypromellose 2910 (also known as HPMC), prepared using three grades of this polymer from two different manufacturers, in order to assess whether polymer chain length or origin affects the mechanical or thermo-mechanical properties of the final films. Hypromellose free films were obtained by casting their aqueous solutions prepared at a specific concentrations in order to obtain the same viscosity for each. The films were stored at room temperature until dried and then examined using a dynamic mechanical analyser. The results of the frequency scans showed no significant differences in the mechanical moduli E′ and E″ of the different samples when analysed at room temperature; however, the grade of the polymer affected material transitions during the heating process. Glass transition temperature, apparent activation energy and fragility parameters depended on polymer chain length, while the material brand showed little impact on film performance. 相似文献
998.
Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort 下载免费PDF全文
Esther Molina‐Montes María‐Jos Snchez Raul Zamora‐Ros H.B Bueno‐de‐Mesquita Petra A. Wark Mireia Obon‐Santacana Tilman Kühn Verena Katzke Ruth C. Travis Weimin Ye Malin Sund Alessio Naccarati Amalia Mattiello Vittorio Krogh Caterina Martorana Giovanna Masala Pilar Amiano Jos‐María Huerta Aurelio Barricarte Jos‐Ramn Quirs Elisabete Weiderpass Lene Angell sli Guri Skeie Ulrika Ericson Emily Sonestedt Petra H. Peeters Isabelle Romieu Augustin Scalbert Kim Overvad Matthias Clemens Heiner Boeing Antonia Trichopoulou Eleni Peppa Pavlos Vidalis Kay‐Tee Khaw Nick Wareham Anja Olsen Anne Tjnneland Marie‐Christine Boutroun‐Rualt Franoise Clavel‐Chapelon Amanda J. Cross Yunxia Lu Elio Riboli Eric J. Duell 《International journal of cancer. Journal international du cancer》2016,139(7):1480-1492
Despite the potential cancer preventive effects of flavonoids and lignans, their ability to reduce pancreatic cancer risk has not been demonstrated in epidemiological studies. Our aim was to examine the association between dietary intakes of flavonoids and lignans and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 865 exocrine pancreatic cancer cases occurred after 11.3 years of follow‐up of 477,309 cohort members. Dietary flavonoid and lignan intake was estimated through validated dietary questionnaires and the US Department of Agriculture (USDA) and Phenol Explorer databases. Hazard ratios (HR) and 95% confidence intervals (CIs) were calculated using age, sex and center‐stratified Cox proportional hazards models, adjusted for energy intake, body mass index (BMI), smoking, alcohol and diabetes status. Our results showed that neither overall dietary intake of flavonoids nor of lignans were associated with pancreatic cancer risk (multivariable‐adjusted HR for a doubling of intake = 1.03, 95% CI: 0.95–1.11 and 1.02; 95% CI: 0.89–1.17, respectively). Statistically significant associations were also not observed by flavonoid subclasses. An inverse association between intake of flavanones and pancreatic cancer risk was apparent, without reaching statistical significance, in microscopically confirmed cases (HR for a doubling of intake = 0.96, 95% CI: 0.91–1.00). In conclusion, we did not observe an association between intake of flavonoids, flavonoid subclasses or lignans and pancreatic cancer risk in the EPIC cohort. 相似文献
999.
Gavini E Spada G Rassu G Cerri G Brundu A Cossu M Sorrenti M Giunchedi P 《The Journal of pharmacy and pharmacology》2011,63(4):472-482
Objectives Nanoparticles were designed for the oral administration and transmucosal colon delivery of drugs. Methods Preparation parameters were studied in order to develop solid pH‐dependent drug‐release nanoparticles, constituted by hydroxypropyl‐β‐cyclodextrin and/or Eudragit® L100 loaded with diclofenac sodium. Nanoemulsions were prepared by the emulsion‐evaporation method using various homogenizers. Different preparative conditions were tested. The emulsions obtained were analysed in terms of size and then dried to obtain solid nanoparticles which were characterized in vitro (particle size, morphology, dissolution, solid state characterization). The effect of nanoparticles on drug permeation through synthetic membranes, colonic pig mucosa and Caco2 cell line were performed. Toxicity studies were carried out to assess the safety of the raw materials used and the nanosystems produced. Key findings Appropriate parameters to obtain nanoemulsions stable enough to be desiccated were determined: Panda NS100L was the most suitable homogenizer for the preparation; particle size ranged between 100 and 600 nm depending on the production method. Solid nanoparticles were obtained by an exsiccation process, which does not modify the mean size. pH‐dependent drug‐release nanoparticles were obtained. The nanoencapsulation process decreased the crystallinity of the drug. Materials and nanoparticles were highly biocompatible. Transmucosal delivery of drug is dependent on the polymer and the test employed: cyclodextrin improved drug permeation across colonic pig mucosa. Conclusions Formulations containing hydroxypropyl‐β‐cyclodextrin represent new colon‐targeted nanoparticles for transmucosal delivery of drugs. 相似文献
1000.
Eugenio Barone Giovanna Cenini Fabio Di Domenico Sarah Martin Rukhsana Sultana Cesare Mancuso Michael Paul Murphy Elizabeth Head D. Allan Butterfield 《Pharmacological research》2011,63(3):172-180
Alzheimer disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory loss, inability to perform the activities of daily living and personality changes. Unfortunately, drugs effective for this disease are limited to acetylcholinesterase inhibitors that do not impact disease pathogenesis. Statins, which belong to the class of cholesterol-reducing drugs, were proposed as novel agents useful in AD therapy, but the mechanism underlying their neuroprotective effect is still unknown. In this study, we show that atorvastatin may have antioxidant effects, in aged beagles, that represent a natural higher mammalian model of AD. Atorvastatin (80 mg/day for 14.5 months) significantly reduced lipoperoxidation, protein oxidation and nitration, and increased GSH levels in parietal cortex of aged beagles. This effect was specific for brain because it was not paralleled by a concomitant reduction in all these parameters in serum. In addition, atorvastatin slightly reduced the formation of cholesterol oxidation products in cortex but increased the 7-ketocholesterol/total cholesterol ratio in serum. We also found that increased oxidative damage in the parietal cortex was associated with poorer learning (visual discrimination task). Thus, a novel pharmacological effect of atorvastatin mediated by reducing oxidative damage may be one mechanism underlying benefits of this drug in AD. 相似文献